Differences
This shows you the differences between two versions of the page.
Next revision | Previous revision | ||
projects:literature [2014/06/24 10:40] – created richter | projects:literature [2014/06/25 13:32] (current) – wade | ||
---|---|---|---|
Line 1: | Line 1: | ||
====== Comparative binding energy analysis (COMBINE) ====== | ====== Comparative binding energy analysis (COMBINE) ====== | ||
+ | |||
+ | First description of the COMBINE analysis method : {{pubmed> | ||
+ | |||
+ | |||
+ | ---- | ||
+ | |||
- {{pubmed> | - {{pubmed> | ||
- | - Comparative binding energy COMBINE analysis for understanding the binding determinants of type II dehydroquinase inhibitors. \\ Peón A, Coderch C, Gago F, González-Bello C. \\ ChemMedChem. 2013 May; | + | - {{pubmed> |
- {{pubmed> | - {{pubmed> | ||
- {{pubmed> | - {{pubmed> | ||
Line 19: | Line 25: | ||
- {{pubmed> | - {{pubmed> | ||
- {{pubmed> | - {{pubmed> | ||
- | - Marta Murcia, | + | - Marta Murcia, Antonio Morreale, Angel R. Ortiz: Comparative Binding Energy Analysis Considering Multiple Receptors: A Step toward 3D-QSAR Models for Multiple Targets. J. Med. Chem., 2006, 49 (21), pp 6241–6253. [[http:// |
- {{pubmed> | - {{pubmed> | ||
- {{pubmed> | - {{pubmed> | ||
- | - Rebecca C. Wadem Stefan Henrich, Ting Wang: Using 3D protein structures to derive 3D-QSARs. Drug Discovery Today: Technologies, | + | - Rebecca C. Wade, Stefan Henrich, Ting Wang: Using 3D protein structures to derive 3D-QSARs. Drug Discovery Today: Technologies, |
- {{pubmed> | - {{pubmed> | ||
- {{pubmed> | - {{pubmed> |